Amebocyte Lysate Market experiencing steady growth driven by 2037
The Amebocyte Lysate Market was valued at over USD 612.3 million in 2024 and is projected to reach approximately USD 1.8 billion by the end of 2037. This represents a compound annual growth rate (CAGR) of around 11.3% during the forecast period from 2025 to 2037. The market is expected to experience robust growth, driven by the increasing demand for endotoxin detection and the widespread use of Amebocyte Lysate in various industries like pharmaceuticals, biotechnology, and medical diagnostics. Amebocyte Lysate Industry Demand Amebocyte Lysate is derived from the blood cells of the horseshoe crab, Limulus polyphemus , and is primarily used in endotoxin testing. This testing is crucial for ensuring the safety and sterility of pharmaceutical products, medical devices, and biotechnology applications. The primary use of Amebocyte Lysate lies in the Limulus Amebocyte Lysate (LAL) assay, which detects endotoxins (toxins derived from bacterial cell walls) in medical products and ...